APA (7th ed.) Citation

Terasaki, M., Nagashima, M., Nohtomi, K., Kohashi, K., Tomoyasu, M., Sinmura, K., . . . Hirano, T. (2013). Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice. PLoS ONE, 8(8), 1. https://doi.org/10.1371/journal.pone.0070933

Chicago Style (17th ed.) Citation

Terasaki, Michishige, et al. "Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice." PLoS ONE 8, no. 8 (2013): 1. https://doi.org/10.1371/journal.pone.0070933.

MLA (9th ed.) Citation

Terasaki, Michishige, et al. "Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice." PLoS ONE, vol. 8, no. 8, 2013, p. 1, https://doi.org/10.1371/journal.pone.0070933.